[Influence of antisense oligonucleotide targeting Chk1/2 on apoptosis of K562 cell induced by DDP]

Wei Huang1, Yao-Zhen Zhang, Jian-Feng Zhou

  • 1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Insights

Antisense oligonucleotides targeting Chk1 and Chk2 enhance cisplatin-induced apoptosis in K562 leukemia cells by inhibiting cell-cycle progression. These findings suggest Chk1 and Chk2 as potential therapeutic targets for leukemia treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Cisplatin (DDP) is a chemotherapy drug used to treat various cancers, including leukemia.
  • Understanding the mechanisms of DDP-induced apoptosis and cell-cycle arrest is crucial for optimizing cancer therapy.
  • Chk1 and Chk2 are key kinases involved in DNA damage response and cell-cycle regulation.

Purpose of the Study:

  • To investigate the effect of DDP on K562 cell-cycle progression.
  • To evaluate the role of antisense oligonucleotides targeting Chk1/2 in DDP-induced apoptosis of K562 cells.
  • To identify potential therapeutic targets for leukemia.

Main Methods:

  • K562 cells were treated with DDP, and cell-cycle changes were analyzed using flow cytometry.
  • Chk1/2 protein expression was assessed via Western blot and confocal microscopy after transfection with antisense oligonucleotides.
  • Apoptosis induction by DDP was measured by flow cytometry following antisense oligonucleotide transfection.

Main Results:

  • DDP treatment resulted in S-phase cell-cycle arrest in K562 cells at 10 micromol/L.
  • Transfection with antisense oligonucleotides effectively inhibited Chk1/2 protein expression.
  • The frequency of DDP-induced apoptosis was significantly increased by antisense oligonucleotides targeting Chk1 and/or Chk2, with combined targeting showing the greatest effect.

Conclusions:

  • Chk1 and Chk2 play a significant role in DDP-induced cell-cycle arrest and apoptosis in K562 cells.
  • Targeting Chk1 and Chk2 with antisense oligonucleotides can enhance the efficacy of DDP in leukemia treatment.
  • Chk1 and Chk2 represent promising therapeutic targets for leukemia.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...